Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | ABBV:NYQ since announced | Transaction value |
---|---|---|
Aliada Therapeutics Inc | -7.27% | 1.40bn |
Celsius Therapeutics Inc | 1.77% | 250.00m |
Cerevel Therapeutics Holdings Inc | 20.48% | 8.70bn |
ImmunoGen Inc | 25.77% | 10.22bn |
Data delayed at least 15 minutes, as of Nov 22 2024 14:31 GMT.